المؤلفون: Yi-Long Wu, MD, Shun Lu, MD, PhD, James Chih-Hsin Yang, MD, PhD, Jianying Zhou, MD, Takashi Seto, MD, Myung-Ju Ahn, MD, PhD, Wu-Chou Su, MD, Noboru Yamamoto, MD, PhD, Dong-Wan Kim, MD, PhD, Jolanda Paolini, MSc, Tiziana Usari, BSc, Laura Iadeluca, PhD, Keith D. Wilner, PhD, Koichi Goto, MD, PhD

المصدر: JTO Clinical and Research Reports, Vol 3, Iss 10, Pp 100406- (2022)

مصطلحات موضوعية: Asia, Crizotinib, NSCLC, Phase 2, ROS1, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: http://www.sciencedirect.com/science/article/pii/S2666364322001308Test; https://doaj.org/toc/2666-3643Test

الوصول الحر: https://doaj.org/article/7369e36175e44454b80a3ac673b3634fTest

المؤلفون: Scott N. Gettinger, MD, Rudolf M. Huber, MD, PhD, Dong-Wan Kim, MD, PhD, Lyudmila Bazhenova, MD, Karin Holmskov Hansen, MD, Marcello Tiseo, MD, Corey J. Langer, MD, FACP, Luis G. Paz-Ares Rodríguez, MD, PhD, Howard L. West, MD, Karen L. Reckamp, MD, MS, Glen J. Weiss, MD, Egbert F. Smit, MD, PhD, Maximilian J. Hochmair, MD, Sang-We Kim, MD, PhD, Myung-Ju Ahn, MD, PhD, Edward S. Kim, MD, FACP, Harry J.M. Groen, MD, PhD, Joanna Pye, MS, Yuyin Liu, PhD, Pingkuan Zhang, MD, Florin Vranceanu, MD, PhD, D. Ross Camidge, MD, PhD

المصدر: JTO Clinical and Research Reports, Vol 3, Iss 9, Pp 100385- (2022)

مصطلحات موضوعية: Anaplastic lymphoma kinase, ALK tyrosine kinase inhibitor, Brigatinib, Crizotinib, Non–small-cell lung cancer, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: http://www.sciencedirect.com/science/article/pii/S2666364322001096Test; https://doaj.org/toc/2666-3643Test

الوصول الحر: https://doaj.org/article/78d40f5a880944a8b24323de142222e5Test

المؤلفون: Alexander Drilon, MD, Chao-Hua Chiu, MD, Yun Fan, MD, Byoung Chul Cho, MD, PhD, Shun Lu, MD, PhD, Myung-Ju Ahn, MD, PhD, Matthew G. Krebs, MD, PhD, Stephen V. Liu, MD, Thomas John, MD, Gregory A. Otterson, MD, Daniel S.W. Tan, MD, Tejas Patil, MD, Rafal Dziadziuszko, MD, PhD, Erminia Massarelli, MD, PhD, Takashi Seto, MD, Robert C. Doebele, MD, PhD, Bethany Pitcher, MSc, Nino Kurtsikidze, MD, Sebastian Heinzmann, PhD, Salvatore Siena, MD

المصدر: JTO Clinical and Research Reports, Vol 3, Iss 6, Pp 100332- (2022)

مصطلحات موضوعية: Entrectinib, Intracranial efficacy, NSCLC, ROS1 fusions, Treatment post-crizotinib, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: http://www.sciencedirect.com/science/article/pii/S266636432200056XTest; https://doaj.org/toc/2666-3643Test

الوصول الحر: https://doaj.org/article/46b674c9f39d4db4b8d61e682c4faee9Test

المؤلفون: Jiyun Lee, MD, Aaron C. Tan, BSc, M.B.B.S., PhD, FRACP, Siqin Zhou, MSc Statistics, Shinkyo Yoon, MD, PhD, Siyang Liu, MD, PhD, Ken Masuda, MD, Hidetoshi Hayashi, MD, PhD, Ullas Batra, MD, DM, Dong-Wan Kim, MD, PhD, Yasushi Goto, MD, PhD, Sze Huey Tan, PhD, Yi-Long Wu, MD, Dae Ho Lee, MD, PhD, Daniel S.W. Tan, BSc, M.B.B.S., MRCP, PhD, Myung-Ju Ahn, MD, PhD

المصدر: JTO Clinical and Research Reports, Vol 3, Iss 1, Pp 100261- (2022)

مصطلحات موضوعية: KRAS, Non–small cell lung cancer, Asian, Time to next treatment, Overall survival, Immunotherapy, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: http://www.sciencedirect.com/science/article/pii/S266636432100120XTest; https://doaj.org/toc/2666-3643Test

الوصول الحر: https://doaj.org/article/45d393969fda454f81842b5e420fbb77Test

المؤلفون: Seong Bok Jang, PhD, Kyeong Bae Kim, PhD, Sujin Sim, MS, Byoung Chul Cho, MD, PhD, Myung-Ju Ahn, MD, PhD, Ji-Youn Han, MD, PhD, Sang-We Kim, MD, PhD, Ki Hyeong Lee, MD, PhD, Eun Kyung Cho, MD, PhD, Nahor Haddish-Berhane, PhD, Jaydeep Mehta, PharmD, PhD, Se-Woong Oh, PhD

المصدر: JTO Clinical and Research Reports, Vol 2, Iss 10, Pp 100224- (2021)

مصطلحات موضوعية: Non–small cell lung cancer, Tyrosine kinase inhibitor, Lazertinib, Cardiac toxicity, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: http://www.sciencedirect.com/science/article/pii/S2666364321000837Test; https://doaj.org/toc/2666-3643Test

الوصول الحر: https://doaj.org/article/ff220c17e38940e2b6f3066799fe6c45Test

المساهمون: Myung-Ju Ahn, MD, PhD

المصدر: A Randomized, Open Label, Phase II Study Comparing Pemetrexed Plus Cisplatin Followed by Pemetrexed Until Progression Versus Pemetrexed Alone Until Progression in Non-small Cell Lung Cancer Patients Who Have Progressed on First Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI)

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT03050437Test

المساهمون: Myung-Ju Ahn, MD, PhD

المصدر: Phase II Trial of BIBF1120 (Nintedanib) in Patients With Recurrent or Metastatic Salivary Gland Cancer of the Head and Neck : a Multicentre Phase II Study

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT02558387Test